DOI: 10.1055/s-00035331

Revista Urología Colombiana / Colombian Urology Journal

References

Böhm M, Baumhäkel M, Teo K. , et al; ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators.
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials.

Circulation 2010;
121 (12) 1439-1446

Download Bibliographical Data

Access:
Access: